T2CURE
t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics to provide new treatment options to patients suffering from cardiovascular diseases like myocardial infarction or peripheral vascular diseases.
T2CURE
Social Links:
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2006-01-01
Address:
Frankfurt, Hessen, Germany
Country:
Germany
Website Url:
http://www.t2cure.de
Total Employee:
11+
Status:
Active
Contact:
+49-69-7561 4687 0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Nginx ReCAPTCHA GoDaddy DNS Hetzner Parallels Plesk Panel Usercentrics
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Curagen Corporation
CuraGen Corporation, a biopharmaceutical development company, develops novel therapeutics for the treatment of cancer.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Investors List
KfW
KfW investment in Series A - t2cure
Entrepreneurs Fund
Entrepreneurs Fund investment in Series A - t2cure
Official Site Inspections
http://www.t2cure.de
- Host name: lxsrv001.loginer.de
- IP address: 88.198.250.150
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "t2cure"
t2cure - Crunchbase Company Profile & Funding
T2cure is a biopharmaceutical company develops novel progenitor cell based …See details»
t2cure GmbH - Frankfurt am Main, Germany - bionity.com
T2cure GmbH is a biopharmaceutical company engaged in the field of stem cell-based regenerative medicine. It develops and markets autologous bone marrow-derived progenitor …See details»
t2cure 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for t2cure. Use the PitchBook Platform to explore the full profile.See details»
t2cure GmbH - Drug pipelines, Patents, Clinical trials - Synapse
Explore t2cure GmbH with its drug pipeline, therapeutic area, technology platform, , Drug:t2c-007, t2c-002, t2c-001.See details»
t2cure Company Profile - Office Locations, Competitors, Revenue …
See insights on t2cure including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
t2cure GmbH Company Profile | Hamburg, Hamburg, Germany
Popular Search: Scientific Research and Development Services Professional, Scientific, and Technical Services Printer Friendly View Address: Winterhuder Marktplatz 6-7 22299, …See details»
t2cure - Products, Competitors, Financials, Employees, …
Compare t2cure to Competitors Intarcia Therapeutics Intarcia Therapeutics is a biotech company that focuses on the development of biologics and peptides for the treatment of cardio-renal …See details»
t2cure
We would like to show you a description here but the site won’t allow us.See details»
t2cure | VentureRadar
T2cure Germany Privately Held t2cure is dedicated to the development of novel regenerative therapeutic agents based on mononuclear cells that are obtained from the patient's bone …See details»
t2cure (t2cure GmbH) - startbase.de
T2cure Entwicklung regenerativer Therapeutika auf Basis von mononuklären Zellen, die aus dem Knochenmark des Patienten gewonnen werden.See details»
t2cure GmbH - Company Profile and News - Bloomberg Markets
Company profile page for t2cure GmbH including stock price, company news, executives, board members, and contact informationSee details»
t2cure GmbH - Orphanet
T2cure GmbH Bettinastr. 35-37 60325 FRANKFURT AM MAIN GERMANY Phone 1: 49 (0)69 7561 4687 8 Contact email: [email protected] Institution's website Contacts Professionals: …See details»
T2cure - Company Profile - Tracxn
T2cure's Competitors and alternates Who are the competitors of T2cure? Top competitor s of T2cure include Tenaya Therapeutics, Portola Pharma and MyoKardia.See details»
t2cure - Company Profile | ConnectFlux
T2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics to provide new treatment options to patients suffering from cardiovascular diseases like …See details»
T2cure GmbH - BioCentury Company Profiles - BCIQ
Mar 17, 2014 T2cure GmbH - BioCentury Company Profiles for the biopharma industrySee details»
t2cure - VentureRadar
T2cure is dedicated to the development of novel regenerative therapeutic agents based on mononuclear cells that are obtained from the patient's bone marrow. These cells have the …See details»
t2cure (t2cure GmbH) - Startbase
T2cure Development of regenerative therapeutics based on mononuclear cells derived from the patient's bone marrow.See details»
t2cure GmbH - Frankfurt am Main, Deutschland - bionity.com
T2cure widmet sich der Entwicklung neuartiger regenerativer Therapeutika auf Basis von mononuklären Zellen, die aus dem Knochenmark des Patienten gewonnen werden. Diese …See details»
t2c-001 - Drug Targets, Indications, Patents - Synapse
May 28, 2025 t2c-001, Initially developed by t2cure GmbH, Now, its global highest R&D status is Pending, Therapeutic Areas: Cardiovascular Diseases,Other Diseases.See details»
t2cure GmbH: Erstmals Qualität eines Produkts zur Zelltherapie …
May 27, 2010 Die Europäische Arzneimittel-Agentur EMA hat jetzt die Qualität eines „Arzneimittels für Neuartige Therapien“ des Stammzell-Entwicklers t2cure GmbH zertifiziert. …See details»